Pay in 4 interest-free payments of $25.50 Learn more
Ships within 48 hours · Estimated delivery Jul 27 - Aug 1
AP-III-a4 is the first
C75 treatment of rodent adipocytes and hepatocytes and human breast cancer cells increases fatty acid oxidation and ATP levels by increasing CPT-1 activity
InChi: InChI=1S/C19H29NO3/c1-12(2)7-14-11-20-6-5-13-8-18(22-3)19(23-4)9-15(13)16(20)10-17(14)21/h8-9
5-b]pyridin-1-yl}piperidine-1-carboxylate
IC50 value: 7 (pIC50) Target: P2X7 in vitro: In cells expressing human P2X7 receptors
(-)-Epicatechin gallate - CAS# 1257-08-5 Size:Solid 10 mg AP-III-a4 is the firstEpicatechin gallate (ECG) is a flavan 3 ol, a type of flavonoid, present in green tea. It is also reported in buckwheat and in grape. The tea component epicatechin gallate is being researched because in vitro experiments showed it can reverse methicillin resistance in bacteria like Staphylococcus aureus. If confirmed, this means the combined intake of a tea extract containing this component might also enhance the effectiveness of methicillin treatment